Chemical modification of the naturally occurring phlorophenone antimicrobial agent caespitin is described. These modifications include variations in the phenone side chain, substitution with prenyl, allyl, and benzyl in the 4-position of the phlorophenone nucleus, and ring cyclizations via etherification to give furan and chroman compounds. Several of these derivatives show enhanced in vitro potency over caespitin. Studies on the development of microbial resistance against these compounds show that no or very little resistance developed after several passes of these compounds in representative microbial strains.
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, and Microsporum canis NCPF 351. The organisms were maintained on Sabouraud dextrose agar (SDA; Oxoid CM41) until used.
MIC determinations. The MIC was determined by a tube dilution method. Standard inocula for the tests on bacteria were prepared by incubating slopes of TSA inoculated with the organisms for 24 h at 37°C, from which suspensions yielding ca. 106 CFU/ml were obtained for use in the experiments. Twofold serial dilutions of each test compound were prepared in brain-heart infusion (BHI; Oxoid CM225) broth down to 1 jig/ml. A growth control of BHI broth was included in each series. To each of the prepared sets of concentrations of each test compound was added 0.1-ml portions of the organism suspensions. The MIC was defined as the lowest concentration of a compound preventing visual growth after 48 h at 37°C. Suspensions of the two yeasts, C. albicans and C. tropicalis, obtained from SDA cultures were diluted in sterile physiological saline to give 106 CFU/ml.
Cultures of the molds in Sabouraud liquid medium (SLM; Oxoid CM146) were kept at 4°C until used and then incubated at 37°C for 5 to 14 days. For use, the suspensions were diluted to contain ca. 106 CFU/ml. Concentrations of each of the compounds were prepared in SLM in twofold steps from 100 to 0.1 ,ug/ml. The same procedure for testing against the bacteria was used for the fungi, only with SLM. Growth controls of SLM were included in each series and acted as indicators to determine the time (5 to 15 days, 37°C) at which the test broths were examined for evidence of growth. The MIC was similarly indicated by the lowest concentration of test compound to prevent growth.
MBC determinations. Subcultures were made from all the broths showing no growth as well as from the growth controls. The subcultures were made onto BHI agar (Oxoid CM375) for the bacteria and onto SDA for the fungi. The plates were incubated at 37°C for 48 h for bacteria and 5 to 15 days for fungi. After incubation the plates were examined for growth, and the lowest concentration allowing no evident growth was recorded as the MBC.
Screening for antimicrobial resistance. The microorganisms used were S. aureus NCTC 6571A, S. pyogenes NCTC 8198, and C. albicans ATCC 10231, from which standard inocula containing 106 CFU/ml were obtained. Six compounds were tested in two series of three compounds each, the first series including compounds C-1, C-31, and C-33 and the second series compounds C-13, C-24, and C-39. General procedure for the preparation of allyl-, prenyl-, and benzylphlorophenones (C-1 and C-6 through C-32). The general method previously reported by us (1), in which the appropriate phlorophenone is treated with either allyl-, prenyl-, or benzylchloride in an alkaline two-phase (aqueous-ether) system and catalyzed by CuCl, was used. The compounds produced, the analytical method used, and the appropriate references are as follows. 2- 5,7-Dihydroxy-2,2-dimethyl-6-(4-methylpentanoyl)chroman (C-36) and 5,7-dihydroxy-2,2-dimethyl-8-(4-methylpentanoyl)chroman (C-37): 2-(4-Methylpentanoyl)-4-(3-methylbuten-2-yl)phloroglucinol (C-1, 2 g) was suspended in benzene (25 ml). Trifluoroacetic acid (1.5 ml) was added, and the mixture was stirred for 6 h at room temperature. Chromatography of the resulting product yielded C-36 and C-37 in a ratio of about 2:3. These chromans both recrystal- 
(t).
To distinguish between C-36 and C-37, both chromans were methylated with dimethyl sulfate to yield the two dimethoxy products 5,7-dimethoxy-2,2-dimethyl-6-isocaproyl chroman (36dc) and 5,7-dimethoxy-2,2-dimethyl-8-isocaproyl chroman (37dc), of which the 1H NMR spectra were consecutively recorded in CDCl3 and in C6D6 to observe the solvent-induced shifts of the methoxy singlets (4). In Fig. 2 , both methoxy signals in the spectrum of 37dc exhibit large upfield shifts in the C6D6 spectrum compared with the CDCl3 spectrum. Recording of the spectrum of 36dc in C6D6 reveals a very small upfield shift of one methoxy signal, indicating steric inhibition of solvation due to orthoortho adjacency of large substituents (thus assigned to the methoxy protons on C-5). The other signal shifts to 83.32, a drastic upfield shift from the position of the signal in the CDCl3 spectrum, representing the methoxy group in the 7-position which is flanked on one side by the aromatic proton.
5,7-Dihydroxy-2,2-dimethyl-8-butyryl chroman (C-35): Following the procedure outlined above, the reaction of C-19 with trifluoroacetic acid gave rise to two chromans, of which the chroman with the longest column retention time (silica; benzene-ethyl acetate, 9:1), 5,7-dihydroxy-2,2-dimethyl-8-butyryl chroman (C-35), was 5,7-Dihydroxy-2,2-dimethyl-6-nonanoyl chroman (C-38) and 5,7-dihydroxy-2,2-dimethyl-8-nonanoyl chroman (C-39): Using the procedure for the preparation of C-35, C-36, and C-37 described above, the reaction of 2-nonanoyl-4-(3- methylbuten-2-yl)phloroglucinol (C-29) with trifluoroacetic phenone moiety (C-6 and C-16) or the alk-2-enyl substituents acid gave rise to C-38 and C-39 after column chromatogra-(C-3, C-4, and C-5) or both (C-2) were included in the series. phy. C-38: mp 108 to 1100C, 3C NMR (8 the phenone side chain generally seemed to enhance activity 2,4-Dibutyryl-6-(propen-2-yl)phloroglucinol (C-42): 2- within a structural class (C-8 versus C-12 and C-13 for allyl Butyryl-4-(propen-2-yl)phloroglucinol (C-8) was treated by phlorophenones; C-17 versus C-23 and C-1 for prenyl the procedure described for the preparation of C-33 to yield phlorophenones). Lengthening beyond a critical carbon C-42 after chromatography: mp 86 to 90°C, '3C NMR (8, chain length, however, seemed to lead to diminished activity DMSO-d6), 205.8(s, 2C), 170.9(s), 168.2(s, 2C), 136.8(d), (C-29).
(ii) Introduction of a benzyl moiety in the place of 113.8(t), 104.1(s), 103.6(s, 2C), 45.8(t, 2C), 26.1(t), 17.5(t, allyl or prenyl likewise tended to enhance activity (C-30, 2C), and 13.7(q, 2C).
RESULTS AND DISCUSSION
The synthesis of a series of caespitin (C-1)-related compounds was identified as the principal objective. Initial modification of the mother compound included both lengthening and shortening of the phenone side chain and expansion of the 3-position to include propen-2-yl, 3-methylbuten-2-yl, and benzyl moieties. To determine the effects of branching, alicyclic, and aromatic substitution and chlorination and etherification of the side chain, representatives of each of these classes of compounds were synthesized (C-9, C-11, C-14, C-15, and C-27). Compounds lacking either the C-31, and C-32). (iii) Phenone disubstitution with retention of all three phenolic hydroxyl groups seemed to drastically enhance activity (C-33). These apparent structure-activity relationships are currently being investigated further. Antimicrobial resistance. In the series of tests with the first group of compounds (compounds C-1, C-31, and C-33) ISB was used for the bacterial strains. During the course of the experiments it was found that S. aureus was giving higher MICs than expected (according to Tables 1 and 2 ), while S. pyogenes was giving less vigorous growth than usual. Accordingly, a trial was designed to compare the MICs of C-13, C-24, and C-39 against S. aureus ATCC 6538 (as used previously), S. aureus NCTC 6571A, and S. pyogenes NCTC 8198 in both ISB and BHI broth. The results are given in Table 3 .
The differences in sensitivity were due mainly to the use of ISB rather than the use of a different strain of S. aureus, and growth of S. pyogenes was improved in BHI broth (Table 3) . BHI was thus used for tests with the second group of compodnds. Results for the initial MIC determinations, the passages, and the cross-resistance experiments are given in Tables 4, 5 , and 6. It can be readily seen from Table 5 that the resistance of S. aureus to streptomycin increased dramatically, while its resistance to nitrofurantoin increased marginally in the first series and much more in the second series. S. pyogenes did not show the same dramatic increase with streptomycin in either series of tests, and C. albicans showed no increase in resistance to nystatin. The organisms thus behaved as expected against the reference antimicrobial compounds. Assessment of the results with the experimental compounds was therefore made on the basis of whether the results with S. aureus and S. pyogenes approximated more closely those obtained with streptomycin or nitrofurantoin, and whether the results obtained with C. albicans showed greater increases in resistance with the experimental compounds than it did with nystatin.
In the first series (Table 5 , experiment 1), the MICs of none of the experimental compounds showed any significant increase against either S. aureus or S. pyogenes. The MIC of nystatin for C. albicans remained fixed after 10 passages, and no significant increase was seen with any of the experimental compounds. In tests with the second group of compounds (Table 5 , 2), the MIC of compound C-39 for S. aureus rose significantly within 10 passages, whereas that of C-13 and C-24 showed a moderate rise. With S. pyogenes the MIC of the compounds rose eightfold. With C. albicans the MIC of nystatin as well as of C-13, C-24, and C-39 remained constant. The increases observed in the MIC of C-13 and C-24 for both S. aureus and S. pyogenes were deemed experimentally significant, and it was thus considered desirable to include both these compounds, together with C-39, in tests for cross-resistance with other antimicrobial compounds.
In the cross-resistance studies with the passaged strains of S. aureus, no evidence of increased resistance to any of the antimicrobial agents was seen except with amikacin and chloramphenicol ( Table 6 ). The strains passaged in C-13 and C-39 showed increased resistance, but since the strains passaged in streptomycin and nitrofurantoin showed a similar increase this result is extremely difficult to interpret. The passaged strains of S. pyogenes showed no evidence of increased resistance to any of the tested antimicrobial agents. It is notable that the strains of S. pyogenes passaged in both streptomycin arid nitrofurantoin gave evidence of increased resistance to amikacin. Reactions of the microorganisms to passage in these compounds correlated far more closely to passage in nitrofurantoin than to passage in streptomycin.
A certain measure of success has been achieved in elucidating broad structure-activity correlations within the range of phlorophenone antimicrobial compounds reported. Several of the compounds, particularly the diphenone C-33, show significant improvement in activity against both bacteria and fungi over caespitin. None of the test compounds showed any evidence that microbial resistance to their activity was likely to develop rapidly. Furthermore, no evidence was found that exposure to the activity of these compounds resulted in any increase in resistance to a very wide range of commonly used antimicrobial agents.
